Mednet Logo

For high-volume metastatic CRPC to bone, what dosing schedule of zoledronic acid or denosumab do you use?

Community PollStarted

What dosing schedule do you use for bone modifying agents for mCRPC with high volume bone metastasis?

50 physicians have voted

Join Mednetto vote and see how they answered.